Hospitals as Investors

Recorded Live at the White Hat Life Science Investor Conference on September 19, 2024 at the Phoenix Convention Center.
Moderated by Jason Jardine, Partner, Knobbe Martens
At Knobbe Martens, Jason’s clients include fast-growth and emerging companies seeking to acquire their first patent as well as middle market and major corporations with thousands of IP assets and multiple families of patents. Jason’s clients are international in scope, with special attention to California and Arizona businesses. His patent law experience spans the full range of life science disciplines, including biotechnology, pharmaceuticals, neutraceuticals and medical devices, and also chemistry, clean technology and hydrogen fuel cells, semiconductors, metal works/mining, action sports and fashion. He is also skilled in the area of computer science inventions related to hospital and emergency data management and the gamification of data.
Panelists:
Jamaine K. Aggrey, Director, Corporate Development, Mayo Clinic (Arizona)
Jamaine joined the Corporate Development team at Mayo Clinic Arizona (MCA) as a director in 2024. He is responsible for assisting MCA leadership in achieving their goals for growth and innovation. Prior to Mayo, Jamaine worked in corporate development and M&A roles with leading investment banking, financial service, and private equity companies. Jamaine has his BA in Economics from Brown University, and an MBA in Finance from The Wharton School at The University of Pennsylvania.
Kiran Avancha, PhD, Chief Innovation Officer, HonorHealth
Dr Kiran Avancha, is the inaugural Chief Innovation Officer for HonorHealth. He has been with HonorHealth-system for the past 7+ years. Prior to that role he successfully ran strategy and operations for HonorHealth Research Institute as their Chief Operations Officer. Under his direction HRI underwent a growth trajectory of 3-fold revenues and grew the team from 70 FTE to 200+ FTEs. He is also a healthcare & biotech entrepreneur, investor, mentor, and advisor for several medical, health-tech and device startups. As a PhD trained scientist and a licensed clinical pharmacist (RPh), he has over 16+ years of strategic, clinical, research and business leadership experience in biotech, healthcare innovation, business development, corporate strategy, M&A, and clinical development in industry, healthcare, and academia. Dr Avancha had successfully fundraised over $50M from VCs, PEs, HNIs and health-systems to build programs for both non-profit as well as for-profit sectors.